Seriously, some of these comments - you would think those that invest on the sharemarket would be aware of these simple mechanisms..
I 100% agree with @phlipper - this is a great outcome.
As per the announcement, here is the deal...
"Exercise price ($3.46 per share) is the volume weighted average price (VWAP) at which the Company's shares were
traded on the ASX in the 5 days preceding the date of issue of the Options.
- Vested options may be exercised no earlier than 1 year after the issue date.
- All options lapse 4 years after the issue date.
- Options are subject to the following vesting conditions:
(a) when the Company determines to progress NNZ-2591 to a Phase 2b or Phase 3 clinical trial following a positive Phase
2 clinical trial outcome, or executes a partnering transaction for NNZ-2591;
(b) when the Company executes a partnering transaction for trofinetide outside North America, or submits a Marketing
Authorisation Application for trofinetide in the European Union, the United Kingdom or Japan.
(c) on acceptance by the US FDA of the filing of a New Drug Application for trofinetide.
- The options carry no entitlement to vote or participate in new issues."
What this means for those unaware of finance mechanisms and employee share schemes...
# Gerry can choose to pay $3.46 per share for up to 500,000 shares not before 3/2/2023 but by 3/2/2027.
# Lauren can choose to pay $3.46 per share for up to 250,000 shares not before 3/2/2023 but by 3/2/2027.
# other non-key personnel/employees have been issued 700,000 shares which they too can choose to pay $3.46 per share not before 3/2/2023 but by 3/2/2027
NOTE: These arent freebies. If the SP is under $3.46 then the options are worthless and wont be exercised.
Obviously this is a huge incentive for the employees to ensure the SP to be higher than it is now - and is part of their salary/employment schemes. IMO this would have been a major part of both Gerry and Lauren's remuneration...otherwise NEU would be paying more salary.
My only hope is that each employee in NEU gets options on some sort of scale - as IMO it is a much better reward/performance mechanism than free shares at discounted VWAP...which most companies do.
- Forums
- ASX - By Stock
- NEU
- Ann: Notification regarding unquoted securities - NEU
NEU
neuren pharmaceuticals limited
Add to My Watchlist
0.85%
!
$12.85

Ann: Notification regarding unquoted securities - NEU, page-8
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$12.85 |
Change
-0.110(0.85%) |
Mkt cap ! $1.598B |
Open | High | Low | Value | Volume |
$12.82 | $13.05 | $12.53 | $6.559M | 511.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1657 | $12.83 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$12.85 | 6303 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1657 | 12.830 |
2 | 3312 | 12.750 |
1 | 1224 | 12.730 |
3 | 3229 | 12.720 |
1 | 1299 | 12.700 |
Price($) | Vol. | No. |
---|---|---|
12.850 | 6303 | 1 |
12.890 | 7731 | 5 |
12.910 | 1229 | 1 |
12.920 | 1474 | 2 |
12.950 | 1299 | 1 |
Last trade - 16.10pm 17/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
RC1
REDCASTLE RESOURCES LIMITED
Ronald Miller, Non-Executive Director
Ronald Miller
Non-Executive Director
SPONSORED BY The Market Online